| Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein C Karthika, R Sureshkumar, M Zehravi, R Akter, F Ali, S Ramproshad, ... Life 12 (6), 897, 2022 | 42 | 2022 |
| Fungal L-asparaginase: Strategies for production and food applications MC da Cunha, JG dos Santos Aguilar, RR de Melo, ST Nagamatsu, F Ali, ... Food research international 126, 108658, 2019 | 42 | 2019 |
| Dihydropyrimidinones scaffold as a promising nucleus for synthetic profile and various therapeutic targets: A Review S Khasimbi, F Ali, K Manda, A Sharma, G Chauhan, S Wakode Current Organic Synthesis 18 (3), 270-293, 2021 | 31 | 2021 |
| Functional Thermoresponsive Hydrogel Molecule to Material Design for Biomedical Applications S Pardeshi, F Damiri, M Zehravi, R Joshi, H Kapare, MK Prajapati, ... Polymers 14 (15), 3126, 2022 | 30 | 2022 |
| Physicochemical characterization and compatibility study of roflumilast with various pharmaceutical excipients F Ali, R Kumar, PL Sahu, GN Singh Journal of Thermal Analysis and Calorimetry 130 (3), 1627-1641, 2017 | 24 | 2017 |
| Advances on Synthesis, Derivatization and Bioactivity of Isatin: A Review G Chauhan, DP Pathak, F Ali, R Bhutani, G Kapoor, S Khasimbi Current organic synthesis, 2020 | 22 | 2020 |
| Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells C Karthika, R Sureshkumar, M Zehravi, R Akter, F Ali, S Ramproshad, ... Life 12 (6), 811, 2022 | 21 | 2022 |
| Teprotumumab (Tepezza): from the discovery and development of medicines to USFDA approval for active thyroid eye disease (TED) treatment F Ali, A Chorsiya, V Anjum, A Ali International Ophthalmology 41 (4), 1549-1561, 2021 | 21 | 2021 |
| Synthetic approaches for oxazole derivatives: A review K Neha, F Ali, K Haider, S Khasimbi, S Wakode Synthetic Communications 51 (23), 3501-3519, 2021 | 17 | 2021 |
| Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease F Ali, A Ilyas Current Research in Translational Medicine 70 (3), 103343, 2022 | 15 | 2022 |
| A systematic review on phytochemicals for the treatment of dengue F Ali, A Chorsiya, V Anjum, S Khasimbi, A Ali Phytotherapy Research 35 (4), 1782-1816, 2021 | 15 | 2021 |
| Quantitative characterization and pharmaceutical compatibility between teneligliptin and widely used excipients by using thermal and liquid chromatography tandem mass … F Ali, U Nandi, M Trivedi, A Prakash, M Dahiya, PL Sahu, R Kumar, ... Journal of Thermal Analysis and Calorimetry 132 (1), 385-396, 2018 | 11 | 2018 |
| Current regulatory landscape of nanomaterials and nanomedicines: A global perspective F Ali, K Neha, S Parveen Journal of Drug Delivery Science and Technology 80, 104118, 2023 | 10 | 2023 |
| Development and Validation of a RP-HPLC Method for Simultaneous Estimation of Antitubercular Drugs in Solid Lipid Nanoparticles. S Khatak, M Khatak, F Ali, A Rathi, R Singh, GN Singh, H Dureja Indian Journal of Pharmaceutical Sciences 80 (6), 2018 | 9 | 2018 |
| In vitro Evaluation of Isatin derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers cell lines: A Review G Chauhan, DP Pathak, F Ali, P Dubey, S Khasimbi Anti-cancer agents in medicinal chemistry, 2021 | 8 | 2021 |
| Size-Dependent Antibacterial, Antidiabetic, and Toxicity of Silver Nanoparticles Synthesized Using Solvent Extraction of Rosa indica L. Petals SK Balu, S Andra, F Damiri, A Sivaramalingam, MV Sudandaradoss, ... Pharmaceuticals 15 (6), 689, 2022 | 7 | 2022 |
| Application of an LC/HPLC method development and validation for the simultaneous estimation of Amitriptyline hydrochloride and chlordiazepoxide in tablet dosage form by using a … F Ali, GN Singh Scholars Research Library 7 (10), 172-177, 2015 | 7 | 2015 |
| Virosome: An engineered virus for vaccine delivery H Ali, M Akbar, B Iqbal, F Ali, NK Sharma, N Kumar, A Najmi, M Albratty, ... Saudi Pharmaceutical Journal 31 (5), 752-764, 2023 | 6 | 2023 |
| Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers F Ali, K Neha, G Chauhan Archives of Pharmacal Research 45 (5), 309-327, 2022 | 6 | 2022 |
| Inebilizumab-cdon: USFDA Approved for the Treatment of NMOSD (Neuromyelitis Optica Spectrum Disorder) F Ali, K Sharma, V Anjum, A Ali Current Drug Discovery Technologies 19 (1), 22-28, 2022 | 6 | 2022 |
Dharam Pal PathakDelhi Institute of Pharmaceutical Sciences and Research (DIPSAR), DPSRUVerified email at dpsru.edu.in
